Showing results (251-260 of 390) with videos related to
Sort By:
Pageof 39
Der Pathologe|April 20, 2017
[The pathology of adverse events with immune checkpoint inhibitors]V H Koelzer, K Glatz, L Bubendorf, et al.Contemporary Clinical Trials Communications|June 10, 2025
Links between self-monitoring data collected through smartphones and smartwatches and the individual disease trajectories of adult patients with depressive disorders: Study protocol of a one-year observational trialHanna Reich, Simon Schreynemackers, Rebeka Amin, et al.Neuropharmacology|June 20, 2012
Enhanced mGlu5-receptor dependent long-term depression at the Schaffer collateral-CA1 synapse of congenitally learned helpless ratsMarco Pignatelli, Barbara Vollmayr, Sophie Helene Richter, et al.Swiss Medical Weekly|May 20, 2019
Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort StudyEmanuel Lengwiler, Susanne Stampf, Alfred Zippelius, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseasesM J Pittet, A Zippelius, D E Speiser, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 17, 2015
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activityNarasimha Rao Uda, Volker Seibert, Frank Stenner-Liewen, et al.Cancer Immunology, Immunotherapy : CII|April 17, 2020
PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockadeMarcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.Immuno-Oncology Technology|February 17, 2022
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platformV H Koelzer, P Herzig, I Zlobec, et al.Oncoimmunology|January 9, 2018
The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitorsHeinz Läubli, Viktor H Koelzer, Matthias S Matter, et al.Pageof 39